|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-7-13
|
|
pubmed:abstractText |
Recent metaphase cytogenetic studies suggested that specific chromosomal abnormalities are of prognostic significance in patients with multiple myeloma (MM). Because the true incidence of chromosomal abnormalities in MM is much higher than that detected by metaphase analysis, we used interphase fluorescence in situ hybridization (FISH) to determine the prognostic value of specific chromosomal aberrations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AckermannJJ,
pubmed-author:DrachJJ,
pubmed-author:FritzEE,
pubmed-author:GisslingerHH,
pubmed-author:HeinzRR,
pubmed-author:HuberHH,
pubmed-author:JägerUU,
pubmed-author:KönigsbergRR,
pubmed-author:KaufmannHH,
pubmed-author:KittlerHH,
pubmed-author:KrömerEE,
pubmed-author:LudwigHH,
pubmed-author:NösslingerTT,
pubmed-author:RiedeUU,
pubmed-author:SimonitschII,
pubmed-author:ZojerNN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
804-12
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10673522-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10673522-Bone Marrow Cells,
pubmed-meshheading:10673522-Chromosome Aberrations,
pubmed-meshheading:10673522-Chromosome Deletion,
pubmed-meshheading:10673522-Chromosome Disorders,
pubmed-meshheading:10673522-Chromosomes, Human, Pair 11,
pubmed-meshheading:10673522-Chromosomes, Human, Pair 13,
pubmed-meshheading:10673522-Chromosomes, Human, Pair 17,
pubmed-meshheading:10673522-Cytogenetics,
pubmed-meshheading:10673522-Female,
pubmed-meshheading:10673522-Forecasting,
pubmed-meshheading:10673522-Humans,
pubmed-meshheading:10673522-In Situ Hybridization, Fluorescence,
pubmed-meshheading:10673522-Incidence,
pubmed-meshheading:10673522-Interphase,
pubmed-meshheading:10673522-Male,
pubmed-meshheading:10673522-Metaphase,
pubmed-meshheading:10673522-Middle Aged,
pubmed-meshheading:10673522-Multiple Myeloma,
pubmed-meshheading:10673522-Multivariate Analysis,
pubmed-meshheading:10673522-Plasma Cells,
pubmed-meshheading:10673522-Prognosis,
pubmed-meshheading:10673522-Regression Analysis,
pubmed-meshheading:10673522-Remission Induction,
pubmed-meshheading:10673522-Survival Rate,
pubmed-meshheading:10673522-Trisomy
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
|
|
pubmed:affiliation |
First Department of Internal Medicine, Divisions of Clinical Oncology, University of Vienna, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
